|
Multiple sclerosis
Citations 381-390 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Interferon ß-1a in primary progressive MS: An exploratory, randomized, controlled trial
- S.M. Leary, D.H. Miller, V.L. Stevenson, P.A. Brex, D.T. Chard, and A.J. Thompson
Neurology 2003; 60: 44-51.
[Abstract]
[Full text]
[PDF]
- ARTICLES
IFNß lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS
- E. Waubant, D. Goodkin, A. Bostrom, P. Bacchetti, J. Hietpas, R. Lindberg, and D. Leppert
Neurology 2003; 60: 52-57.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Immunization and MS: A summary of published evidence and recommendations
- Olivier T. Rutschmann, Douglas C. McCrory, and David B. Matchar
Neurology 2002; 59: 1837-1843.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Course and prognosis in early-onset MS: Comparison with adult-onset forms
- I. L. Simone, D. Carrara, C. Tortorella, M. Liguori, V. Lepore, F. Pellegrini, A. Bellacosa, A. Ceccarelli, I. Pavone, and P. Livrea
Neurology 2002; 59: 1922-1928.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
Hypersomnia in MS
- K. Iseki, T. Mezaki, Y. Oka, K. Terada, H. Tomimoto, Y. Miki, and H. Shibasaki
Neurology 2002; 59: 2006-2007.
[Full text]
[PDF]
- ARTICLES
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions
- E. Bergers, J.C.J. Bot, C.J.A. De Groot, C.H. Polman, G.J. Lycklama à Nijeholt, J.A. Castelijns, P. van der Valk, and F. Barkhof
Neurology 2002; 59: 1766-1771.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Impaired renal function in progressive multiple sclerosis
- P.A. Calabresi, H. Austin, M.K. Racke, A. Goodman, P. Choyke, H. Maloni, and H.F. McFarland
Neurology 2002; 59: 1799-1801.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, comparative study of interferon ß-1a treatment regimens in MS: The EVIDENCE Trial
- H. Panitch, D.S. Goodin, G. Francis, P. Chang, P.K. Coyle, P. O’Connor, E. Monaghan, D. Li, and B. Weinshenker
Neurology 2002; 59: 1496-1506.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized, double-blind, dose-comparison study of weekly interferon ß-1a in relapsing MS
- M. Clanet, E.W. Radue, L. Kappos, H.P. Hartung, R. Hohlfeld, M. Sandberg-Wollheim, M.F. Kooijmans-Coutinho, E.C. Tsao, and A.W. Sandrock
Neurology 2002; 59: 1507-1517.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4–positive Russians
- O. O. Favorova, T. V. Andreewski, A. N. Boiko, M. A. Sudomoina, A. D. Alekseenkov, O. G. Kulakova, A. V. Slanova, and E. I. Gusev
Neurology 2002; 59: 1652-1655.
[Abstract]
[Full text]
[PDF]
|
|
